Key facts
| Recalling firm | Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number DTMB1D1; Implantable Cardioverter Defibrillators |
| Classification | Class I |
| Recall number | Z-1761-2023 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds. |
What this classification means
A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class I, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number DTMB1D1; Implantable Cardioverter Defibrillators should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF). FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)’s FDA history
Argus HQ has recorded 120 total FDA actions tied to Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF): 0 warning letters, 120 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Is CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number DTMB1D1; Impla recalled?
- Yes. FDA lists a Class I recall by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) for CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number DTMB1D1; Implantable Cardioverter Defibrillators, reported 20230628, with status "Ongoing." FDA recall number: Z-1761-2023.
- What is the recall class for Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)'s recall?
- FDA classified this recall as Class I. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death.
- Why was CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number DTMB1D1; Impla recalled?
- FDA's recall record states the reason as: There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.
- Who should I contact about this recall?
- Contact Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)- Recall: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Class I recall: ICD-VR DVMD3D1 PRIMO MRI, Model Number DVMD3D1; Implantable Cardioverter Defibr… →
- Recall: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Class I recall: CRTD DTMB2D4 AMPLIA MRI OUS DF4, Model Number DTMB2D4; Implantable Cardioverter… →
- Recall: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Class I recall: ICD COBALT XT HF QUAD OUS, Model Number DTPA2QQG; Implantable Cardioverter Defi… →
- Recall: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Class I recall: CRTD COBALT XT HF QUAD MRI IS4 DF1, Model Number DTPA2Q1; Implantable Cardiover… →
- Recall: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Class I recall: ICD-VR DVFB1D1 VISIA AF MRI US DF1, Model Number DVFB1D1; Implantable Cardiover… →
- Recall: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Class I recall: ICD-VR DVAB1D1 VISIA AF US IS1/DF1, Model Number DVAB1D1; Implantable Cardiover… →
- Recall: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Class I recall: ICD CROME DR MRI IS1 DF4, Model Number DDPC3D4; Implantable Cardioverter Defibr… →
- Recall: Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) — Class I recall: ICD COBALT DR MRI IS1 DF4, Model Number DDPB3D4; Implantable Cardioverter Defib… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2023). FDA Recall Database: Class I Recall: CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number… by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF). Digital Empire LLC. Retrieved from https://argushq.ai/recall/medtronic-cardiac-rhythm-and-heart-failure-crhf-z-1761-2023-2023-06-28
"FDA Recall Database: Class I Recall: CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number… by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)." Argus HQ Research, Digital Empire LLC, 2023, argushq.ai/recall/medtronic-cardiac-rhythm-and-heart-failure-crhf-z-1761-2023-2023-06-28.
Argus HQ Research. "FDA Recall Database: Class I Recall: CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number… by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/recall/medtronic-cardiac-rhythm-and-heart-failure-crhf-z-1761-2023-2023-06-28.
@misc{argushq_argushq_ai_recall_medtronic_cardiac_rhythm_and_heart_failure_crhf_z_1761_2023_2023_06_28_2023,
title = {FDA Recall Database: Class I Recall: CRTD DTMB1D1 AMPLIA MRI US DF1, Model Number… by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)},
author = {{Argus HQ Research}},
year = {2023},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/medtronic-cardiac-rhythm-and-heart-failure-crhf-z-1761-2023-2023-06-28},
note = {Accessed: July 17, 2026}
}Source: FDA.gov — Recalls ↗

